A universal problem for refugees is the loss of vital health records. ISoP Egypt Chapter is working to reduce medication errors and improve reporting for this vulnerable community.

Despite seven years of crisis, a dedicated team of health professionals have put Syria on the world pharmacovigilance map.

Since achieving full membership of the WHO Programme for International Drug Monitoring (PIDM) in 1996, Oman has steadily built an active, well-respected national centre.

A recent study puts the spotlight on the extent of substandard and falsified medicines in Iraq, the reasons behind the problem, and the steps needed to address it.

In 2018, the SFDA launched a strategic project for regional pharmacovigilance centres, to enhance activities among health institutions across the Kingdom of Saudi Arabia.

Oman holds workshop aimed to enhance herbovigilance measures in the country, to ensure safe, effective and good-quality herbal products on the Omani market.

Lebanon implemented its pharmacovigilance system and boosted safety reporting all while dealing with the effects of COVID-19. A glance at the 143rd country in the global programme.